Skip to main content
. 2016 Sep 20;11(2):148–156. doi: 10.1111/irv.12419

Table 2.

Clinical characteristics of pediatric patients with severe, acute respiratory infection with and without laboratory‐confirmed influenza, Jingzhou, China, April 5, 2010 to April 8, 2012

Characteristicsa Confirmed Influenza (n=1774) (%) Negative for Influenza (n=12 705) (%) P‐value b Total (n=15 354)c (%)
Symptoms at hospital admission
Cough 1157 (65) 7205 (57) <.05 8836 (61)
Sore throat 401 (23) 3531 (28) <.05 4098 (27)
Rhinorrhoea 323 (18) 1748 (14) <.05 2192 (14)
Sputum production 135 (8) 1089 (9) .173 1304 (9)
Dyspnoea 39 (2) 556 (4) <.05 642 (4)
Vomiting 69 (4) 721 (6) <.05 859 (6)
Diarrhea 28 (2) 540 (4) <.05 609 (4)
Abdominal pain 27 (2) 186 (2) .849 228 (2)
Signs at hospital admission
Temperature (T, °C)
T<36.0 0 6 (0.05) <.05 7 (0.05)
36.0≤T<37.0 251 (14) 2071 (6) 2460 (16)
37.0≤T<38.0 373 (21) 3048 (24) 3624 (24)
38.0≤T<39.0 676 (38) 4461 (35) 5459 (36)
T≥39.0 474 (27) 3119 (25) 3804 (25)
Abnormal breath sounds on auscultation 537 (30) 3799 (30) .751 4579 (30)
Tachypnea 1 (0.1) 25 (0.2) .361 29 (0.2)
Pneumonia Diagnosis
Clinically diagnosed as pneumonia at hospital admission 238 (13) 1911 (15) .071 2291 (15)
Clinically diagnosed as pneumonia at hospital admission and chest radiograph performed 195/238 (82) 1623/1911 (85) .227 1938/2291 (85)
Radiographic diagnosis of pneumonia 161/195 (83) 1401/1623 (86) .154 1674/1938 (86)
Chest radiograph performed at hospital admission and during hospitalization 807 (46) 5600 (44) .262 6841 (45)
Radiographic diagnosis of pneumonia 246/807 (30) 2188/5600 (39) <.05 2583/6841 (38)
Clinical laboratory findings
Leucopeniad 165/1525 (11) 557/11 055 (5) <.05 777/13 299 (6)
Leukocytosise 282/1525 (19) 3657/11 055 (33) <.05 4188/13 299 (31)
Anemiaf 269/1520 (18) 2313/11 014 (21) <.05 2748/13 250 (21)
Elevated erythrocyte Sedimentation rateg 66/158 (42) 641/1086 (59) <.05 777/1349 (58)
C‐reactive protein >8 mg/L 117/476 (25) 1431/3397 (42) <.05 1622/4040 (40)
Treatment
Received antibiotics before hospital admission 670/1343 (50) 4529/9831 (46) <.05 5490/11 802 (47)
Received antibiotics during hospitalization 1750 (99) 12 461 (98) .097 15 056 (98)
Received corticosteroids during hospitalization 164 (9) 1591 (13) <.05 1880 (12)
Received oseltamivir during hospitalization 2 (0.1) 21 (0.2) 1.000 23 (0.1)
Supplemental oxygen required 16 (0.9) 183 (1.4) .086 216 (1)
Mechanical ventilation 1 (0.1) 2 (0.05) .324 5 (0.1)
Admitted to ICU 1 (0.1) 18 (0.1) .722 21 (0.1)
Complications
Neurologic disorders 3 (0.2) 11 (0.1) .241 20 (0.1)
Respiratory failure 1 (0.1) 8 (0.1) 1.000 10 (0.1)
Cardiac failure 1 (0.1) 11 (0.1) 1.000 14 (0.1)
Hepatic dysfunction 2 (0.1) 3 (0.01) .117 7 (0.1)
Clinical course, median days (IQR)
From illness onset to hospital admission 2 (1–3) 2 (1–3) .860 2 (1–3)
From hospital admission to discharge or death 5 (3–6) 5 (3–6) .936 5 (3–6)
Clinical outcome
Died during hospitalization 0 3 (0.02) .221 3 (0.02)
Died within 30 d after discharge 1 (0.1) 4 (0.03) .480 5 (0.03)

ICU, intensive care unit; IQR, interquartile range.

a

Data presented as no. (%) of patients unless otherwise indicated. Denominators for testing of fewer cases than full group are indicated. Percentages may not total 100 because of rounding. Data only include patients who provided specimens for influenza virus testing.

b

The P‐values are comparisons between “pediatric SARI patients with confirmed influenza infection” and “pediatric SARI patients without influenza infection”, and statistically significant as P<.05.

c

There were 875 (6%) patients without NP/OP collection.

d

Defined as a reduction in the circulating WBC count to <4000/μL.

e

Defined as a reduction in the circulating WBC count to >10 000/μL.

f

Defined as a reduction in the hemoglobin in grams per liter (Hb<110 g/L).

g

Raised erythrocyte sedimentation rate defined as >20 mm/h.